Another Superbug in 35 States Now - No medicines to combat it - Not the Same As The One from India

So, a Superbug was created where the mortality rate is 30% to 60%.  It has now spread to 35 states.

They say there are no medicines to combat this superbug.

Please be Aware this is NOT the Superbug that has come out of India from the Medical Travelers there, this is Another Superbug in the Hospitals here in the U.S.

Bacteria that are able to survive every modern antibiotic are cropping up in many U.S. hospitals and are spreading outside the USA, public health officials say.

The bugs, reported by hospitals in more than 35 states, typically strike the critically ill and are fatal in 30% to 60% of cases.
The bacteria are equipped with a gene that enables them to produce an enzyme that disables antibiotics. The enzyme is called Klebsiella pneumoniae carbapenamase, or KPC. It disables carbapenam antibiotics, last-ditch treatments for infections that don't respond to other drugs.

Carbapenam-resistant germs are diagnosed mostly in hospital patients and are not spreading in the community. They're far more common nationwide than bacteria carrying a gene called NDM-1 that made headlines this week, Fishman says.

Those NDM-1 bacteria, named for the city of New Delhi, are rare in the USA and have been found mainly in people who obtain medical treatment in India, Arjun Srinivasan of the U.S. Centers for Disease Control and Prevention (CDC) said Thursday.

We are approaching Winter in the Northern Hemisphere - I sincerely Hope, Everyone has Vitamin D and C besides Multi Vitamins and a Great Thing to have is Food Grade 35% Hydrogen Peroxide (adds oxygen to cells - cures almost everything - dilute to 3%) - Keep your body strong and Please Do NOT Get a Vaccine!

A Super Bug that Really Kills Now - Mortality Rate at 55%! No Cure and Spreading Fast - Morphs - Horizontal Gene Transfer! In Japan, India, Britian and U.S. - Vaccines the Cause?

UPDATE - 1:09pm - Fox News Is Carrying the Story now - Says cases are in 3 States in the U.S. now.
California, Massachusetts and Illinois

_______________________________________________________________
_______________________________________________________________
Well, it seems the labs might have finally come up with a Super Bug that has a mortality rate at over 55% from what I can see.  Right now in Japan of the 58 confirmed cases, 32 have died!  

This is serious and at what point will we hear about it here in the U.S.?

Also - something to think about.... This came from those who Traveled TO India and came back to their respective country from getting surgery done in India!  Think about that!  When I was going to travel to India, I was going to have to get a ton of different VACCINATIONS to do so.  Now, my question is "What was in those Vaccinations"?  WHY travelers TO India, what did they have in their body to cause them to get a superbug?  Why didn't it start with those who Lived in India first, from all that I have read, it started with Medical Tourist!  Do you understand what I am saying?  It does not make sense,   Was there one vaccine they all happened to get that was the same and from the same company?

An article in an India paper has the following information

Tokyo, Sep 11: Japan has confirmed another five cases of infection with Acinetobacter, an antibiotic-resistant bacteria, formally know as ‘New Delhi metallo-beta-lactamase-1 enzyme (NDM-1)’. 

The cases from Teikyo University Hospital have brought the total number of people infected with the superbug to 58 in the country.

Of the 58 people, 32 have died, including nine whose deaths were likely caused directly by the infection, the Xinhua news agency reports.

NDM-1 is a type of bacteria resistant to carbapenems, one of the antibiotics of last resort for many bacterial infections.

The superbug’s is formally named after New Delhi, as it was reportedly discovered in the Indian capital.

According to reports, it has spread to Britain and the United States through travelers who had surgery in India.

The first death directly attributed to the superbug was reported last month in Belgium. 

I just found another article about it - Just now released.

New Indian superbug 'a global threat' 

A new superbug from India thought to be resistant to nearly every known antibiotic poses a global threat, scientists warned on Monday, urging health authorities to track the bacteria.

"There is an urgent need, first, to put in place an international surveillance system over the coming months and, second, to test all the patients admitted to any given health system" in as many countries as possible, said Patrice Nordmann of France's Bicetre Hospital.

"For the moment, we don't know how fast this phenomenon is spreading... it could take months or years, but what is certain is that is will spread," he told AFP, noting that measures have already been agreed in France and are under discussion in Japan, Singapore and China.

The so-called "superbug," dubbed NDM-1 (New Delhi metallo-beta-lactamase 1), and its variants appear to have originated in India and were first detected in Britain in 2007.

For example, scientists have determined that the NDM gene "is very mobile, hopping from one bacteria to another," he said.

"medical tourist" appeared to have brought the bacteria to Britain.

More information:

We have found that the superbug has the potential to get copied and transferred between bacteria, allowing it to spread rapidly. If it spreads to an already hard-to-treat bacterial infection, it can be turn more dangerous," Kumarasamy said.

Scientists have tracked down a drug-resistant superbug that infects patients and causes multiple organ failure to Indian hospitals but doctors here see in it the germ of a move to damage the country's booming medical tourism industry.

The 'superbug' resistant to almost all known antibiotics has been found in UK patients treated in Indian hospitals. Named after the Indian capital, it is a gene carried by bacteria that causes gastric problems, enters the blood stream and may cause multiple organ failure leading to death.

35 Mystery Deaths In India, Not Swine Flu 11/9/09 9:33PM est

35 Mystery Deaths In India, Not Swine Flu

In the last 45 days there have been 35 deaths in India as the Sassoon Hospital and the Doctors there still don't have the answer as to what caused them, though they know it was Not the Swine Flu.

From Article:

Doctors at Sassoon hospital anxiously await report on 35 patients who died of infection that caused symptoms similar to swine flu

Doctors at Sassoon Hospital, who are in the thick of the swine flu battle, are a worried lot. Thirty-five patients with swine flu-like symptoms died in the last 45 days at the hospital, and not one of them tested positive for swine flu. The doctors still don't know what caused the death of these patients.

Tell the world
"We requested the National Institute of Virology (NIV) to check tissue samples from these patients for eight to 10combinations of the HN virus subtype like H1N2 or H2N2. It is extremely important that the virus is identified so we can decide on the course of treatment," said Dr Arun Jamkar, dean of Sassoon Hospital, which has been dubbed as the epicentre of the swine flu activity in the state.

On October 28, doctors at Sassoon shared the data on these deaths with the Center for Disease Control, Atlanta, USA, and virologists across the world in a videoconference.

Despite repeated attempts, Dr A C Mishra, director of NIV, remained unavailable for comment. Dr Mandeep Chaddha, deputy director, NIV, said she wasn't authorised to speak to the media.

Impact on vaccine
Dr Pravin Shengare, joint dire-ctor, Directorate of Medical Education and Research, who attended the video-conference, said, "The NIV's report won't have an effect on vaccine production, but it is important to know if another dominant virus sub-type is circulating. If this is the case, a detailed analysis of deaths that occurred due to unexplained symptoms will have to be undertaken," he said.

"If it is found that there is a different strain of the virus, then that strain should ideally be incorporated in the H1N1 vaccine that is being developed by NIV. It is also important to understand how potent that virus is," said
JP Muliyil, senior scientist and epidemiologist at Christian Medical College, Vellore.

Shengare, however, pointed out that the WHO had recommended that a monovalent vaccine against H1N1 be developed. Modifying a vaccine so it provides protection from other viruses would take too much time and effort, he felt. "Even if a new virus sub-type is circulating, the H1N1 vaccine that is being developed won't be useless, as it can still be used to fight swine flu. If there is another virus, we'll have to deal with it separately," said Shengare.